Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis
Clinical trial NCT04112303 · COMPLETED
Trial details
- NCT number
- NCT04112303
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2021-03-26
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.